Blueprint is a venture capital firm focused on brain health and neurotechnology, backing companies developing evidence-based, non-invasive brain measurement and related applications across wellness, medicine, cognition tracking, depression research and clinical research tools. It is relevant for founders in HealthTech, Biotechnology, Medical Devices, AI and Machine Learning, Deep Tech and Wellness, with investment geography spanning the United States, Europe, Korea, India, Canada, the United Kingdom and Japan.